Senaste nytt från onkologi
ASCO GU 2025
We met leading experts
Get their insight into current studies and new knowledge in oncology
Seneste nyt fra onkologi
Onkologi / Hematologi • Nr. 3 • 2024
- Second-Line Treatment of mRCC – Data Support the Choice of Cabozantinib Monotherapy
- ESMO 2024 – Highlights
- EHA 2024 – A Danish Late-Breaking Abstract Presented
ASCO GI 2025
We met leading experts
Get their insight into current studies and new knowledge in oncology
Nordic Advisory Editorial Board*
*BestPractice Nordic maintains a continuous dialogue with the Nordic Advisory Editorial Panel. This panel aids in proposing editorial themes, bringing attention to new guidelines, essays, relevant clinical issues, and updates from national and international congresses. Please note that the advisory editorial panel is NOT accountable for the content published by BestPractice Nordic. All content undergoes approval by the author.
